Research priorities in epilepsy for the next decade - A representative view of the European scientific community: Summary of the ILAE Epilepsy Research Workshop, Brussels, 17-18 January 2008: Workshop reports

Epilepsia

Volumn 50, Issue 3, 2009, Pages 571-578

  Baulac, Michel ^a   Pitkänen, Asla ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; BRAIN DEVELOPMENT; BRAIN INJURY; CHILDHOOD DISEASE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTOGENESIS; EUROPE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE THERAPY; GENETIC MARKER; HEALTH CARE COST; HUMAN; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; NEUROIMAGING; NEUROSURGERY; NONHUMAN; ORGANIZATION; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEIZURE; SEIZURE THRESHOLD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

EID: 61849130512     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01811.x     Document Type: Conference Paper

References (6)

1. Andlin-Sobocki P, Jönsson B, Wittchen H-U, Olesen J 2005) Costs of disorders of the brain in Europe. Eur J Neurol 12 (Suppl. 1 1 17.
2. Ben-Ari Y, Holmes GL 2006) Effects of seizures on developmental processes in the immature brain. Lancet Neurol 5 : 1055 1063.
3. EUCARE (2003) European White Paper on Epilepsy. Epilepsia 44 (Suppl. 6 1 88.
4. Kwan P, Brodie MJ 2000) Early identification of refractory epilepsy. N Engl J Med 342 : 314 319.
5. Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P 2007) Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 48 : 2224 2233.
6. Rogawski MA, Löscher W 2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5 : 553 564.